Reference
Phelps R, et al. Incidence, management, and outcomes of autoimmune nephropathies following alemtuzumab treatment in patients with multiple sclerosis. Multiple Sclerosis Journal 25: 1273-1288, No. 9, Aug 2019. Available from: URL: http://doi.org/10.1177/1352458519841829
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1813, 17 (2020). https://doi.org/10.1007/s40278-020-80774-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-80774-0